Standardized herbal medicines for the treatment of chronic diseases
The role of purinergic receptor P2X4 signaling of dorsal root ganglia and spinal c...
| Full text | |
| Author(s): Show less - |
Fattori, Victor
[1]
;
Zarpelon, Ana C.
[1]
;
Staurengo-Ferrari, Larissa
[1]
;
Borghi, Sergio M.
[1]
;
Zaninelii, Tiago H.
[1]
;
Da Costa, Fernando B.
[2]
;
Aives, Jose C.
[3]
;
Cunha, Thiago M.
[3]
;
Cunha, Fernando Q.
[3]
;
Casagrande, Rubia
[4]
;
Arakawa, Nilton S.
[4]
;
Vern Jr, Waldiceu A.
Total Authors: 12
|
| Affiliation: | [1] Univ Estadual Londrina, Dept Pathol, Lab Pain Inflammat Neuropathy & Canc, Londrina - Brazil
[2] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, AsterBioChem Res Team, Ribeirao Preto - Brazil
[3] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Lab Inflammat & Pain, Ribeirao Preto - Brazil
[4] Univ Estadual Londrina, Ctr Hlth Sci, Dept Pharmaceut Sci, Londrina - Brazil
Total Affiliations: 4
|
| Document type: | Journal article |
| Source: | FRONTIERS IN PHARMACOLOGY; v. 9, SEP 25 2018. |
| Web of Science Citations: | 3 |
| Abstract | |
Background: Gout is the most common inflammatory arthritis worldwide. It is a painful inflammatory disease induced by the deposition of monosodium urate (MSU) crystals in the joints and peri-articular tissues. Sesquiterpene lactones (SLs) are secondary metabolite biosynthesized mainly by species from the family Asteraceae. It has been demonstrated that SLs present anti-inflammatory, analgesic, antitumoral, antiparasitic, and antimicrobial activities. In this study, we aimed at evaluating the efficacy of the SL budlein A in a model of acute gout arthritis in mice. Methods: Experiments were conducted in male Swiss or male LysM-eGFP mice. Animals were treated with budlein A (1 or 10 mg/kg) or vehicle 30 min before stimulus with MSU (100 mu g/10 mu L, intra-articular). Knee joint withdrawal threshold and edema were evaluated using electronic von Frey and caliper, respectively, 1-15 h after MSU injection. Leukocyte recruitment was determined by counting cells (Neubauer chamber), H\&E staining, and using LysM-eGFP mice by confocal microscopy. Inflammasome components, Il-1 beta and Tnf-alpha mRNA expression were determined by RT-qPCR. IL-1 beta and TNF-alpha production (in vitro) and NF-kappa B activation (in vitro and in vivo) were evaluated by ELISA. In vitro analysis using LPS-primed bone marrow-derived macrophages (BMDMs) was performed 5 h after stimulation with MSU crystals. For these experiments, BMDMs were either treated or pre-treated with budlein A at concentrations of 1, 3, or 10 mu g/mL. Results: We demonstrated that budlein A reduced mechanical hypersensitivity and knee joint edema. Moreover, it reduced neutrophil recruitment, phagocytosis of MSU crystals by neutrophils, and Il-1 beta and Tnf-alpha mRNA expression in the knee joint. In vitro, budlein A decreased TNF-alpha production, which might be related to the inhibition of NF-kappa B activation. Furthermore, budlein A also reduced the IL-1 beta maturation, possibly by targeting inflammasome assembly in macrophages. Conclusion: Budlein A reduced pain and inflammation in a model of acute gout arthritis in mice. Therefore, it is likely that molecules with the ability of targeting NF-kappa B activation and inflammasome assembly, such as budlein A, are interesting approaches to treat gout flares. (AU) | |
| FAPESP's process: | 13/08216-2 - CRID - Center for Research in Inflammatory Diseases |
| Grantee: | Fernando de Queiroz Cunha |
| Support Opportunities: | Research Grants - Research, Innovation and Dissemination Centers - RIDC |
| FAPESP's process: | 11/19670-0 - Mechanisms involved in the pathophysiology of rheumatoid arthritis, pain and sepsis |
| Grantee: | Fernando de Queiroz Cunha |
| Support Opportunities: | Research Projects - Thematic Grants |